Supportive Housing Program for Homelessness
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on housing and health service use, so it's likely you can continue your medications, but please confirm with the study team.
What data supports the effectiveness of the treatment Social Medicine Housing Initiative for homelessness?
Is supportive housing safe for participants?
How does the Social Medicine Housing Initiative treatment differ from other treatments for homelessness?
The Social Medicine Housing Initiative is unique because it combines subsidized housing with site-based social services, aiming to improve health and residential stability for homeless individuals. Unlike other treatments, it focuses on providing stable housing as a foundation for addressing health and social issues, which can lead to greater satisfaction with living situations and improved quality of life.410111213
What is the purpose of this trial?
The study design is a cohort study with a propensity score-matched control group and difference-in-difference analysis to evaluate intervention effectiveness. A hybrid type 1 effectiveness-implementation study framework is used that incorporates mixed methods to determine clinical effectiveness and explore implementation and participant well-being. Participants are selected based on their utilization of health services. Selection favoured those individuals with the most health service utilization. A control group will be created by selecting individuals from administrative hospital records that are propensity-score matched to the individuals in the treatment group (1:4 pair). The hybrid type 1 effectiveness-implementation study framework was used to guide the selection of study aims and outcomes to focus primarily on clinical effectiveness, while also exploring implementation-related factors. The primary objective of the study is to evaluate the impact of the Initiative on the number of emergency department visits and days spent in the hospital. The secondary objectives are to 2) evaluate the impact of the Initiative on program participants' health and well-being, 3) evaluate the implementation of the Initiative and assess program fidelity and barriers, and 4) to calculate the cost avoidance and cost-effectiveness of the Initiative.
Research Team
Andrew Boozary, MD MPP CCFP
Principal Investigator
University Health Network, Toronto
Eligibility Criteria
This trial is for adults who are unhoused and have complex health needs, with frequent hospital visits—specifically, at least 2 inpatient admissions or 6 emergency department visits in the past 6 months. Priority is given to Indigenous people, those without housing recently, women, gender-diverse individuals, and people with disabilities.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants are provided with housing and support services as part of the Social Medicine Housing Initiative
Follow-up
Participants are monitored for health outcomes and healthcare utilization
Data Analysis
Analysis of health data and cost-effectiveness of the program
Treatment Details
Interventions
- Social Medicine Housing Initiative
Social Medicine Housing Initiative is already approved in United States for the following indications:
- Complex health needs in unhoused adults
Find a Clinic Near You
Who Is Running the Clinical Trial?
University Health Network, Toronto
Lead Sponsor